Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, ...13, 14, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-03-09
4:17 pm
Purchase
13GCepton, Inc.
CPTN
Point72 Asset Management L.P.1,815,228
1.2%
1,815,228increase
(New Position)
View
2023-02-23
7:43 pm
Purchase
13GInari Medical, Inc.
NARI
Point72 Asset Management L.P.2,795,352
5.2%
2,795,352increase
(New Position)
View
2023-02-17
4:35 pm
Purchase
13GIovance Biotherapeutics, Inc.
IOVA
Point72 Asset Management L.P.8,114,890
5%
8,114,890increase
(New Position)
View
2023-02-14
4:27 pm
Purchase
13GPrometheus Biosciences, Inc.
RXDX
Point72 Asset Management L.P.3,114,107
6.7%
1,131,546increase
(+57.07%)
View
2023-02-14
4:25 pm
Purchase
13GMarinus Pharmaceuticals, Inc.
MRNS
Point72 Asset Management L.P.3,515,356
7.1%
116,695increase
(+3.43%)
View
2023-02-14
4:23 pm
Purchase
13GGritstone bio, Inc.
GRTS
Point72 Asset Management L.P.7,702,831
9.2%
1,094,273increase
(+16.56%)
View
2023-02-14
4:23 pm
Sale
13GCidara Therapeutics, Inc.
CDTX
Point72 Asset Management L.P.3,868,006
5.4%
-450,034decrease
(-10.42%)
View
2023-02-14
4:22 pm
Purchase
13GFibroGen, Inc.
FGEN
Point72 Asset Management L.P.6,281,645
6.7%
1,615,538increase
(+34.62%)
View
2023-02-14
4:22 pm
Sale
13GAvalo Therapeutics, Inc.
AVTX
Point72 Asset Management L.P.500,737
5.3%
-5,511,939decrease
(-91.67%)
View
2023-02-14
4:21 pm
Sale
13GAnaptysBio, Inc.
ANAB
Point72 Asset Management L.P.2,124,200
7.5%
-157,000decrease
(-6.88%)
View
2023-02-14
4:20 pm
Purchase
13GAbeona Therapeutics Inc.
ABEO
Point72 Asset Management L.P.1,150,648
7.4%
189,778increase
(+19.75%)
View
2023-02-14
4:20 pm
Purchase
13GEos Energy Enterprises, Inc.
EOSE
Point72 Asset Management L.P.5,535,030
6.7%
2,493,265increase
(+81.97%)
View
2023-02-14
4:19 pm
Sale
13GIDEAYA Biosciences, Inc.
IDYA
Point72 Asset Management L.P.69,450
0.1%
-1,984,767decrease
(-96.62%)
View
2023-02-14
4:19 pm
Sale
13GXenon Pharmaceuticals Inc.
XENE
Point72 Asset Management L.P.1,178,501
1.9%
-1,828,637decrease
(-60.81%)
View
2023-02-14
4:18 pm
Sale
13GHealth Catalyst, Inc.
HCAT
Point72 Asset Management L.P.1,920,253
3.5%
-864,631decrease
(-31.05%)
View
2023-02-14
4:18 pm
Sale
13GX4 Pharmaceuticals, Inc.
XFOR
Point72 Asset Management L.P.913,242
1.3%
-719,962decrease
(-44.08%)
View
2023-02-14
4:17 pm
Unchanged
13GCepton, Inc.
CPTN
Point72 Asset Management L.P.0
0%
0
(Unchanged)
View
2023-02-14
4:17 pm
Sale
13GuniQure N.V.
QURE
Point72 Asset Management L.P.1,745,461
3.7%
-1,866,230decrease
(-51.67%)
View
2023-02-14
4:16 pm
Sale
13GTricida, Inc.
TCDA
Point72 Asset Management L.P.167,509
0.3%
-3,117,394decrease
(-94.90%)
View
2023-02-14
4:15 pm
Sale
13GFulcrum Therapeutics, Inc.
FULC
Point72 Asset Management L.P.30,702
0.1%
-2,037,172decrease
(-98.52%)
View
Goto 0, 1, 2, ...13, 14, Next